
PwC advises Sigma Pharmaceuticals Plc on an increase in its asset-based lending facility allowing the business to capitalise on market opportunities
PwC have advised Sigma Pharmaceuticals Plc, one of the UK’s largest independent short-line pharmacy wholesalers, in securing an increased asset-based lending facility of £50m provided by Leumi ABL.